Skip to main content

Africa gets 'holistic' drug discovery centre

By


Munyaradzi Makoni
14 April 2011
http://www.scidev.net/en/sub-suharan-africa/africa-gets-holistic-drug-discovery-centre.html?utm_source=link&utm_medium=rss&utm_campaign=en_subsuharanafrica

[CAPE TOWN] A "holistic" research centre described as the first of its kind in Sub-Saharan Africa to bridge the gap between basic sciences and drug development was launched in South Africa last week (7 April).

The Drug Discovery and Development Centre, known by the acronym H-3D, will focus on developing and testing preclinical drug candidates for diseases afflicting the continent, and will train African scientists in skills needed for drug discovery, integrating medicinal chemistry, biology and pharmacology.

It will allow "Africans to find their own solutions to their own health problems," said Kelly Chibale, founding director and a chemist at University of Cape Town (UCT), which will host the centre.

The aim is to achieve a "critical mass of personnel" to help make Africa competitive enough to attract contracts from the pharmaceutical industry and research organisations, and create jobs in Africa, Chibale said.

"South Africa has a strong reputation in developing basic sciences and clinical studies, so researchers will bridge the gap that has always existed in translating knowledge into new medicines," Chibale told SciDev.Net. But he added that even South Africa, the most technologically advanced economy in Sub-Saharan Africa, has gaps in knowledge and expertise of the drug discovery chain ­ something the centre will try to fill.

Research will focus on drugs for the treatment of malaria, tuberculosis and cardio-vascular diseases.

Mamphela Ramphele, chairperson of the Technology Innovation Agency (TIA), South Africa, said researchers should seize this opportunity to also tackle diseases such as typhoid, cholera and river blindness, which are largely confined to Africa.

But it will be a long time before drugs could start rolling out, Chibale cautioned: "I don't want to create any unrealistic expectations. We will kiss many frogs before meeting the prince."

Timothy Wells, chief scientific officer at the Medicines for Malaria Venture (MMV) told SciDev.Net the centre is an opportunity to provide original home-grown drugs for diseases that developed countries hardly pay attention to.

Apart from the MMV, the centre is collaborating with the US National Institutes of Health's National Institute of Allergy and Infectious Diseases, and pharmaceutical companies such as Novartis and GlaxoSmithKline.

The MMV and the TIA will co-fund H-3D to the tune of 20 million rand (around US$3 million) for the next four years. The MMV will also sponsor mentoring programmes for South African researchers.

--

Comments

Post a Comment

Popular posts from this blog

Medical Practitioners Calls off their strike in Kenya

By
Medical practitioners operating at Kenya's largest public hospital called Kenyatta National Hospital went on strike yesterday and paralysed all medical services within that health institution for 10 hours. They were demanding that the government of Kenya should pay them their due arrears for 11 months adding up to a total of 87 million Kenya shillings. Patients waited patiently in the hospital wards and on long queues for the strike to be called off or solved by the relevant authority. Relevant ministers were at that moment attending a constitution conference at the Kabete about 10 kilometers away from the hospital. When PHM Kenya representative arrived to the hospital, the hospital administration had already made promise to pay the nurses as soon as possible and the nurses agreed to resume back to work this morning. I will be going there at 2:00 pm to meet some officials to see if PHM could be of help to any side. More of this later..... In solidarity. Erick Otieno Owuor
Post a Comment
Read more

It's time

By
---------- Forwarded message ---------- From:   Dr. Sipho S. Moyo, ONE.org   <one-help@list.one.org> Date: Tue, Jun 19, 2012 at 1:36 PM Subject: It's time To: linda@phmovement.org Dear ONE member, In 2003 African leaders made a bold commitment to invest in agriculture, food security and rural development. Yet while some have made notable progress, others have fallen short. It’s time for our leaders to take action. Earlier this year we achieved a major success when, thanks to ONE members like you, Tanzania’s President Kikwete agreed to champion this issue with his fellow leaders. But he needs your support. Leaders are meeting next month in Addis Ababa and we need to make sure they hear our message loud and clear. Click here to automatically sign the petition , which reads: Dear African leaders, It’s time to break the vicious cycle of hunger and poverty. When you meet in Addis Ababa please recommit to investing in agriculture and nutrition to help pull 31 mi...
Post a Comment
Read more

Access to safe abortion remains a dream for many women in Uganda-Universal Health Coverage Must Include Access to Medical Abortion!

By
As we mark the International Universal Health Coverage day, December 12 , under the theme “Keep the Promise”, it is crucial to highlight the World Health Organization (WHO)’s policy incoherence regarding misoprostol and mifepristone. Is the WHO keeping the promise of delivering universal health for all? WHO’s policy incoherence regarding the status of misoprostol and mifepristone constitutes a significant barrier to wider access to safe medical abortion. WHO must keep the promise of UHC and unequivocally endorse prompt low cost access to misoprostol and mifepristone including appropriate advice on usage and precautions. This comment addresses the global issue taking Uganda as a case study.   Access to essential health care is the ‘promise’ of Universal Health Coverage (UHC). It is also a fundamental human right. The mortality burden globally associated with unsafe abortion is horrendous and could be dramatically reduced if prompt low cost access to safe medical abortion ...
Post a Comment
Read more